Published in J Bone Miner Metab on January 01, 2006
Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study. J Clin Endocrinol Metab (2011) 1.15
Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study. Calcif Tissue Int (2011) 0.87
A fruit, milk and whole grain dietary pattern is positively associated with bone mineral density in Korean healthy adults. Eur J Clin Nutr (2014) 0.84
Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period. J Clin Endocrinol Metab (2013) 0.84
Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study. J Bone Miner Metab (2009) 0.82
Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life. Osteoporos Int (2010) 0.77
[Association between sex hormones, bone remodeling markers and bone mineral density in postmenopausal women of Moroccan origin (cross-sectional study)]. Pan Afr Med J (2015) 0.75
The Association between Dehydroepiandrosterone Sulfate (DHEA-S) and Bone Mineral Density in Korean Men and Women. J Bone Metab (2017) 0.75
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1998) 2.95
Sources of estrogen and their importance. J Steroid Biochem Mol Biol (2003) 2.54
Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res (2000) 2.24
Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res (1997) 2.03
Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res (2004) 1.79
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas (1995) 1.67
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab (1994) 1.66
Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest (1996) 1.59
Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab (1998) 1.41
Diet, nutrition and the prevention of osteoporosis. Public Health Nutr (2004) 1.41
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas (1995) 1.37
Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab (2002) 1.23
Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1998) 1.22
Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol (1991) 1.15
Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf) (2000) 1.14
Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res (1997) 0.99
Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study. J Bone Miner Res (1998) 0.98
A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med (1999) 0.94
Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol (Oxf) (2002) 0.91
Prediction of incident osteoporotic fractures in elderly women using the free estradiol index. Osteoporos Int (2004) 0.90
The effect of circulating androgens on bone mineral density in postmenopausal women. Maturitas (2004) 0.88
The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporos Int (2004) 0.88
Dehydroepiandrosterone and diseases of aging. Drugs Aging (1996) 0.88
Molecular and genetic mechanisms of osteoporosis: implication for treatment. Curr Mol Med (2003) 0.87
Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density. J Bone Miner Metab (2004) 0.86
Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency. Osteoporos Int (2003) 0.86
The relationship between sex steroids and bone mineral content in women soon after the menopause. Clin Endocrinol (Oxf) (1991) 0.85
Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos Int (1994) 0.84
Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur. J Bone Miner Metab (2001) 0.83
The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study. J Bone Miner Metab (2002) 0.83
Endogenous sex hormones and bone mineral density among community-based postmenopausal women. Postgrad Med J (1992) 0.83
The pathophysiological implications of circulating androgens on bone mineral density in a normal female population. Steroids (2000) 0.82
The metabolism of vitamin D3 in response to testosterone. Calcif Tissue Int (1997) 0.80
Comparison of the effects of transdermal estrogen, oral estrogen, and oral estrogen-progestogen therapy on bone mineral density in postmenopausal women. J Bone Miner Metab (2002) 0.80
Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. Br J Obstet Gynaecol (1992) 0.76
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin Endocrinol (Oxf) (1998) 0.76
Body weight and/or endogenous estradiol as determinants of cortical bone mass and bone loss in healthy early postmenopausal women. Acta Endocrinol (Copenh) (1992) 0.75
Calcium in women: healthy bones and much more. J Obstet Gynecol Neonatal Nurs (2004) 0.75
Bone density of normal women in relation to endogenous and exogenous oestrogens. Br J Rheumatol (1994) 0.75
Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women. Maturitas (2003) 0.75
Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril (2006) 2.22
EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 - 2005. Clin Chem Lab Med (2006) 2.14
The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: guide to the Register, version 3-2010. Clin Chem Lab Med (2010) 1.68
Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med (2009) 1.58
General Practice as a career choice among undergraduate medical students in Greece. BMC Med Educ (2007) 1.47
Thoracic endometriosis syndrome. Respiration (2007) 1.30
Development of leiomyomas on the uterine remnants of two women with Mayer-Rokitansky-Küster-Hauser syndrome. Fertil Steril (2004) 1.14
The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev (2004) 1.05
Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci (2007) 1.05
Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol (2006) 1.04
Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2005) 0.99
The EC4 European syllabus for post-graduate training in clinical chemistry and laboratory medicine: version 4--2012. Clin Chem Lab Med (2012) 0.99
Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension (2009) 0.99
Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril (2006) 0.98
Fetal growth restriction and postnatal development. Ann N Y Acad Sci (2006) 0.98
Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. J Clin Endocrinol Metab (2010) 0.98
Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol (2012) 0.95
Pathogenesis of endometriosis: the role of defective 'immunosurveillance'. Eur J Contracept Reprod Health Care (2007) 0.93
Menstrual disorders. Endocr Dev (2012) 0.93
Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril (2008) 0.93
Bisphosphonates. Ann N Y Acad Sci (2006) 0.92
The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol (2009) 0.91
Adnexal torsion during pregnancy: report of four cases and review of the literature. J Obstet Gynaecol Res (2008) 0.90
Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatr Drugs (2006) 0.90
Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Curr Diabetes Rev (2010) 0.90
HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol (2013) 0.89
Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecol Endocrinol (2005) 0.89
Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine. Clin Chem Lab Med (2012) 0.89
Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity. Haematologica (2014) 0.89
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril (2002) 0.89
The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development. Endocrine (2007) 0.89
The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem (2007) 0.89
Elevated circulating IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome. Mediators Inflamm (2006) 0.88
Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Küster-Hauser syndrome. J Psychosom Obstet Gynaecol (2009) 0.88
Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism (2011) 0.88
Evaluation of fetal intrapartum hypoxia by middle cerebral and umbilical artery Doppler velocimetry with simultaneous cardiotocography and pulse oximetry. Arch Gynecol Obstet (2003) 0.86
Sigmoid colon cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol (2002) 0.86
Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI. Obesity (Silver Spring) (2010) 0.86
Poor responders in IVF: cancellation of a first cycle is not predictive of a subsequent failure. Ann N Y Acad Sci (2006) 0.86
The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: Code of Conduct, Version 2--2008. Clin Chem Lab Med (2009) 0.86
Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size. Gynecol Oncol (2008) 0.86
Insulin-like growth factor-1 isoform mRNA expression in women with endometriosis: eutopic endometrium versus endometriotic cyst. Ann N Y Acad Sci (2006) 0.85
Review: Impact of mediators present in amniotic fluid on preterm labour. In Vivo (2012) 0.85
Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation. In Vivo (2010) 0.85
Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome. Gynecol Endocrinol (2008) 0.85
Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps. J Obstet Gynaecol Res (2007) 0.85
Apoptosis in atherosclerosis: a mini-review. Mini Rev Med Chem (2008) 0.84
Thyroid function and postpartum mood disturbances in Greek women. J Affect Disord (2009) 0.84
Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol (2008) 0.84
Concurrent imperforate hymen, transverse vaginal septum, and unicornuate uterus: a case report. J Pediatr Surg (2007) 0.84
A unique case of descending salpingitis and functioning endometrium in a Müllerian remnant in a woman with Mayer-Rokitansky-Küster-Hauser syndrome. Fertil Steril (2005) 0.84
High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women. J Hypertens (2012) 0.84
The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study. J Obstet Gynaecol Res (2011) 0.83
Fertility drugs and ovarian cancer risk: a critical review of the literature. Ann N Y Acad Sci (2010) 0.83
Impact of isolated teratozoospermia on the outcome of intrauterine insemination. Fertil Steril (2005) 0.83
The role of genes in the development of Mullerian anomalies: where are we today? Obstet Gynecol Surv (2009) 0.83
Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemia. Am J Hematol (2013) 0.83
Indicative markers of cell proliferation and apoptosis during the perinatal period. Am J Perinatol (2003) 0.82
Association between serum tumor necrosis factor-alpha and corticotropin-releasing hormone levels in women with preterm labor. J Obstet Gynaecol Res (2006) 0.82
Vaginal foreign body in childhood: A multidisciplinary approach. J Paediatr Child Health (2006) 0.82
Osteoprotegerin as a marker of atherosclerosis in diabetic patients. Int J Endocrinol (2013) 0.82
Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Mediators Inflamm (2005) 0.82
Androgens associated with advanced glycation end-products in postmenopausal women. Menopause (2010) 0.82
Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes. Hormones (Athens) (2008) 0.82
Primary amenorrhea in adolescent girls: normal coitus or not? Always take a look in the physician's office. BMC Womens Health (2014) 0.81
Validity of intraoperative gross examination of myometrial invasion in patients with endometrial cancer: a meta-analysis. Acta Obstet Gynecol Scand (2012) 0.81
Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype. J Hypertens (2013) 0.81
Protective effect of NAC preconditioning against ischemia-reperfusion injury in piglet small bowel transplantation: effects on plasma TNF, IL-8, hyaluronic acid, and NO. J Surg Res (2009) 0.81
The influence of total plasma homocysteine and traditional atherosclerotic risk factors on degree of abdominal aortic aneurysm tissue inflammation. Vasc Endovascular Surg (2009) 0.81
Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol (2010) 0.81
Cabergoline as treatment of ovarian hyperstimulation syndrome: a review. Gynecol Endocrinol (2012) 0.80
In vitro fertilization: angiogenic, proliferative, and apoptotic factors in the follicular fluid. Ann N Y Acad Sci (2003) 0.80
Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox 1. Maturitas (2005) 0.80
Adhesion molecules expression in the placental bed of pregnancies with pre-eclampsia. BJOG (2002) 0.80
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study. Neurol Sci (2012) 0.80
Pitfalls of the WHIs: Women's Health Initiative. Ann N Y Acad Sci (2006) 0.80
The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: guide to the Register Version 2-2003 and procedure for re-registration. Clin Chem Lab Med (2003) 0.80
Elevated second trimester amniotic fluid interferon gamma-inducible T-cell alpha chemoattractant concentrations as a possible predictor of preterm birth. J Soc Gynecol Investig (2006) 0.80
The clinical significance of Doppler findings in fetal middle cerebral artery during labor. Eur J Obstet Gynecol Reprod Biol (2003) 0.79
Additive effect of depressed mood and vasomotor symptoms on postmenopausal insomnia. Menopause (2009) 0.79
An evidence based strategy for follow up after breast conserving treatment for breast cancer. J Surg Oncol (2011) 0.79
Effect of sperm treatment with exogenous platelet-activating factor on the outcome of intrauterine insemination. Fertil Steril (2005) 0.79
Apoptosis and proliferation factors in serum and follicular fluid from women undergoing in vitro fertilization. Fertil Steril (2003) 0.79
Serum lipid levels and bone mineral density in Greek postmenopausal women. Gynecol Endocrinol (2012) 0.78
Apolipoprotein E and paraoxonase 1 polymorphisms are associated with lower serum thyroid hormones in postmenopausal women. Clin Endocrinol (Oxf) (2008) 0.78
Alterations in Doppler velocimetry indices of the umbilical artery during fetal hypoxia in labor, in relation to cardiotocography and fetal pulse oximetry findings. Arch Gynecol Obstet (2005) 0.78
Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery. J Soc Gynecol Investig (2006) 0.78
Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors. Gynecol Endocrinol (2012) 0.78
The role of maternal gut hormones in normal pregnancy: fasting plasma active glucagon-like peptide 1 level is a negative predictor of fetal abdomen circumference and maternal weight change. Eur J Endocrinol (2010) 0.78